跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“FBAL”
全部
71
临床试验
37
药物
22
机构
1
资讯
11
9个月前
Processa Pharmaceuticals Reports Promising Phase 2 Data for NGC-Cap Combination in Metastatic Breast Cancer
9个月前
Processa Pharmaceuticals Reports Promising Phase 2 Data for NGC-Cap in Advanced Breast Cancer
去年
Agenus Reports Breakthrough Response Rates for BOT/BAL Combination in Cold Tumors
去年
Agenus Reports Promising Survival Data for Bot/Bal Combination in Colorectal Cancer Treatment
去年
Agenus to Present New Data on BOT/BAL Combination Therapy at AACR IO Meeting
去年
France Approves Compassionate Access for Agenus' BOT/BAL Immunotherapy in Refractory MSS Colorectal Cancer
去年
Balstilimab Plus Botensilimab Shows Enhanced Response in MSS mCRC Without Liver Metastases
2年前
Agenus Highlights Progress of BOT/BAL Program in Q1 2024, Secures $100 Million Royalty Financing
去年
Zydus Lifesciences Secures Exclusive Rights to Agenus' BOT/BAL Cancer Immunotherapy for India and Sri Lanka
去年
Agenus Advances BOT/BAL Combination Therapy with Phase 3 BATTMAN Trial Launch for Metastatic Colorectal Cancer
第 1 页,共 2 页
上一页
下一页